Health ❯ Pharmacology

Medications

GLP-1 Receptor Agonists Paracetamol GLP-1 Drugs Antihypertensives GLP-1 Agonists Weight Loss Drugs Metformin Ozempic Risperidone Dopamine Modulators

Oral Semaglutide Linked to Fewer Heavy Drinking Days in Small Randomized Trial

The result points to oral semaglutide as a potential harm‑reduction option pending larger trials and regulatory review.

Lab Study Finds Many Sweeteners Alter Gut Bacteria

England Reportedly Weighs Viagra Use to Offset Mexico City Altitude

Rutgers Study Finds Current GLP‑1 Use Linked to Weaker Paths From Impulse and Alcohol to Violence

Malaria Fight Advances Fast, WHO Warns Funding Could Stall Gains

Largest Study of Severe Pregnancy Sickness Confirms Key Gene and Finds Six New Leads

BMJ Study Links GLP-1 Drugs to Lower Risk of Problematic Substance Use

Meta-Analysis Finds Nitrous Oxide Offers Rapid, Short-Lived Relief for Depression

Brain Maps of GLP-1 Drugs Point to Paths for Weight Loss Without Nausea

New Studies Tie Surge in Youth Hypertension to Obesity, Show Blood Pressure Falls When Adults Quit Alcohol

ENEM 2025 Question Highlights Gila Monster’s Role in Ozempic’s Origins

X-Linked Gene Kdm6a Tied to Female-Biased Brain Inflammation in UCLA Mouse Study

Study Finds One in Five Ozempic, Wegovy, Mounjaro Users Report Taste Changes

Australian Survey Finds Hyperemesis Gravidarum Driving Tough Choices, Inadequate Relief

Constipation Drug Lubiprostone Slows Kidney Function Decline in Phase II CKD Trial

Tolcapone Boosts Prefrontal Control Signals and Reduces Drinking in Early AUD Trial

Dopamine-Blocking Antipsychotics Stabilize Rare Genital Arousal Disorder

Intranasal Antibody Cuts Mugwort Allergy in Mice, Paving Way for Human Trials

Statins Linked to 39% Drop in 28-Day Mortality for Sepsis Patients

Pharma Experts Warn of Deadly TikTok 'Paracetamol Challenge'